A Clinical Trial of Ginseng in Diabetes

Early Phase 1CompletedNCT00781534

Washington University School of Medicine19 enrolled

Overview

a clinical study of Ginseng its potential affect on diabetes

Comparing three groups (those with \& without normal blood sugar levels) to see if there is any clinically significant change in blood sugar levels in relationship to those taking: 1. ginseng 2. ginsenoside RE (a type of metabolized ginseng) 3. placebo

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

BASIC_SCIENCE

Masking

QUADRUPLE

Enrollment

Conditions

Diabetes

Interventions

GinsengDRUG

Each of the 3 arms will be compared to determine if there is any clinical difference in blood sugars between the 3 groups

GinsengDRUG

ginsenoside REDRUG

active metabolite of ginseng

Placebo (sugar pill)

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * ages 18-65 * healthy, non-diabetic * healthy, impaired glucose tolerance/mild diabetes (no medications required) Exclusion Criteria: * impaired glucose tolerance (borderline diabetes that requires medications) * diabetes (requiring medications) * caffeine sensitivity * known cardiac, peripheral vascular diseases * arrhythmias (irregular heart rhythms)

Locations (1)

Washington University School of Medicine

St Louis, Missouri, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.